Envestnet Asset Management
SWTX

Envestnet Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Envestnet Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-114,274
Closed -$5.04M – 4550
2025
Q1 		$5.04M Sell
114,274
-7,489
-6% -$345K ﹤0.01% 2119
2024
Q4 		$4.4M Buy
121,763
+1,507
+1% +$52.7K ﹤0.01% 2192
2024
Q3 		$3.85M Buy
120,256
+7,830
+7% +$293K ﹤0.01% 2267
2024
Q2 		$4.24M Buy
112,426
+40,781
+57% +$1.72M ﹤0.01% 2136
2024
Q1 		$3.53M Buy
71,645
+5,518
+8% +$255K ﹤0.01% 2218
2023
Q4 		$2.41M Buy
66,127
+4,780
+8% +$125K ﹤0.01% 2348
2023
Q3 		$1.42M Buy
61,347
+39,902
+186% +$1.09M ﹤0.01% 2563
2023
Q2 		$562K Buy
21,445
+5,431
+34% +$143K ﹤0.01% 3138
2023
Q1 		$412K Buy
16,014
+4,538
+40% +$133K ﹤0.01% 3275
2022
Q4 		$298K Sell
11,476
-2,925
-20% -$72.1K ﹤0.01% 3429
2022
Q3 		$411K Buy
14,401
+558
+4% +$16K ﹤0.01% 3140
2022
Q2 		$341K Sell
13,843
-2,553
-16% -$93.4K ﹤0.01% 3287
2022
Q1 		$925K Buy
16,396
+5,763
+54% +$330K ﹤0.01% 2727
2021
Q4 		$659K Buy
10,633
+2,705
+34% +$179K ﹤0.01% 2900
2021
Q3 		$503K Buy
+7,928
New +$611K ﹤0.01% 2961

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Envestnet Asset Management's SWTX Position: Q2 2025 in Review

Envestnet Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 114,274 shares — an estimated $5.04M sold.

Envestnet Asset Management first reported a position in SWTX in Q3 2021 and held it in 15 quarters. The position peaked at $5.04M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Envestnet Asset Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 114,274 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.04M.
  • Envestnet Asset Management first reported a position in SpringWorks Therapeutics in Q3 2021 and held it in 15 quarters.
  • Envestnet Asset Management's SpringWorks Therapeutics position peaked at $5.04M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Envestnet Asset Management's 13F filing for Q2 2025, filed 1 Aug 2025.